Company Overview
Insilico predicts and optimizes biotechnological processes for the food, agro, and healthcare industries. Successful in business since 2001, Insilico provides internationally renowned expertise and unique technology platforms. Insilico collaborates with companies such as Bayer Technology Services, Boehringer Ingelheim, Degussa, DSM, and international research institutes.
Insilico’s competitive advantage is its proven track record of producing new insights and IP for customers in systems biology using its proprietary software, databases and computing facilities. By building better and innovative integrated models of complex cellular processes, Insilico sets new standards in systems biology as a leading solution provider to the Life Sciences industries.
Insilico designs novel- and optimizes existing microbial production processes by building computational models of living cells. Insilico’s experts build genome based metabolic networks of microorganisms and run in silico simulations for pathways to improve the productivity or characteristics of certain strains.
Insilico’s expertise derives from several research laboratories and the company’s co-founders. Insilico is a privately-owned company, located in Stuttgart, Germany.